News
An illustration of a magnifying glass. An illustration of a magnifying glass.
Headquartered in Novo Hamburgo, Rio Grande do Sul, the Brazilian Association of Companies of Components for Leather, Footwear ...
From a range of 'cuts' to sustainability problems, Caoimhe O'Neill explores modern glove designs and the superstitions that ...
Danish drugmaker Novo Nordisk A/S is preparing to launch its blockbuster weight-loss drug Wegovy in India within the next several weeks, sources told Moneycontrol. The move thrusts the company ...
President Trump threatened to levy a new 50% tariff on E.U.-imported goods last week. Novo Nordisk manufactures much of its GLP-1 drugs in Denmark. The president delayed implementation of the ...
Several high-profile backers participated in GlycoEra’s oversubscribed series B. The round was led by Novo Holdings and included other big names such as Roche Ventures, Bristol Myers Squibb, Sofinnova ...
A new café has officially opened its doors in Banbury. NOVO opened in the town's marketplace on Saturday (May 24) with customers quickly trying out the new business. The café's name generally ...
The sudden departure of Novo Nordisk chief executive Lars Fruergaard Jørgensen comes not amid scandal or strategic calamity, but a less fashionable misstep: disappointing the stock market.
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. When Lars Fruergaard Jørgensen came down the grand circular staircase at Novo Nordisk’s headquarters ...
It's plainly apparent that Novo Nordisk has had May 22 circled its calendar since February, when the FDA began the countdown for compounders to stop selling their versions of semaglutide.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results